Expanded autologous NK cells with high expression of NKp30, NKp44 and CD16 were intravenously infused (up to 10 × 106 cells/kg) into lymphoma patients one day after rituximab-combined salvage chemotherapy. Here, FCGR3A is linked to lymphoma.